AstraZeneca has halted its planned £200m ($270m) investment in a research facility in Cambridge, according to reports from ...

FDA chief Martin Makary said the agency will now ‘proactively monitor’ pharma companies for advertising law breaches.

The deal marks the second time Novartis has tapped Monte Rosa’s services in just under year. The US big pharma company paid ...

US-based Amneal Pharmaceuticals has secured approval from the FDA for its 500mg/mL sodium oxybate oral solution.

Zentiva, a Czech producer of generic medications, is poised for a change in ownership as Advent has agreed to sell the ...

A new report by trade body ABPI outlines an alarming drop in British life sciences investment as companies increasingly turn ...

Kashiv BioSciences has entered a partnership with Brazilian biopharmaceutical company CRISTÁLIA to facilitate the marketing ...

AbbVie has struck deals with Rinvoq generic hopefuls as it extends protection for one of its prized assets until 2037.

Health Canada has approved Medison Pharma and Ipsen’s Bylvay to treat cholestatic pruritus in patients aged 12 months and ...

Eli Lilly is seeking a label expansion for earlier use of Jaypirca (pirtobrutinib) in treatment-naïve patients with chronic ...

LB Pharmaceuticals’ public listing comes amid a dry spell for biotech IPOs despite a flurry of activity early in 2025.

Capricor released its response to the FDA publicly after the agency published its CRL for deramiocel without prior warning.